Insilico lands heavily backloaded $2.5B AI drug discovery deal with SK Biopharm - Fierce Biotech

A major AI company signed a $2.5 billion deal with a pharmaceutical company to use AI for discovering new drugs. This investment signals confidence that AI can speed up the slow and expensive drug development process, potentially bringing life-saving medicines to patients faster.